» Articles » PMID: 37193168

Pathogenicity of P.Phe147del in RET in Familial Hirschsprung's Disease

Overview
Journal Am J Transl Res
Specialty General Medicine
Date 2023 May 16
PMID 37193168
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The study aimed to explore the pathogenicity of p.Phe147del in a Hirschsprung'irschspru (HSCR) family and facilitate the deeper understanding of HSCR families.

Methods: Whole-exome sequencing (WES) was performed to decipher a HSCR family. We used a "GlycoEP" tool to analyze RET protein glycosylation. A series of molecular biological approaches including mutated plasmid construction, cell transfection, polymerase chain reaction, immunofluorescence and immunoblotting were introduced to determine the mutation status and altered expression of RET as well as its related genes or proteins. MG132 was applied to analyze the mechanism of mutated RET.

Results: WES and Sanger results revealed that p.Phe147del in-frame mutation (IM) was a potential pathogenetic factor for familial HSCR. Moreover, the IM led to disrupted N-glycosylation of RET accompanied with protein structural change, resulting in the decreased transcriptional and protein level of RET, CCND1, VEGF and BCL2, and the decreased protein level of phosphorylated ERK and STAT3. Further studies revealed that the IM-evoked RET decline was reversed by inhibiting proteosome in a dose dependent manner, thus suggesting that the decrease in intracellular RET protein levels interrupted the transportation of RET protein from the cytoplasm to the cell surface.

Conclusion: The newly found p.Phe147del IM of RET is pathogenic to familial HSCR and it disrupts RET structure and abundance via the proteasome pathway, representing evidence for the early prevention, clinical diagnosis and treatment of HSCR.

References
1.
Diposarosa R, Bustam N, Sahiratmadja E, Susanto P, Sribudiani Y . Literature review: enteric nervous system development, genetic and epigenetic regulation in the etiology of Hirschsprung's disease. Heliyon. 2021; 7(6):e07308. PMC: 8237298. DOI: 10.1016/j.heliyon.2021.e07308. View

2.
Workman M, Mahe M, Trisno S, Poling H, Watson C, Sundaram N . Engineered human pluripotent-stem-cell-derived intestinal tissues with a functional enteric nervous system. Nat Med. 2016; 23(1):49-59. PMC: 5562951. DOI: 10.1038/nm.4233. View

3.
Soret R, Schneider S, Bernas G, Christophers B, Souchkova O, Charrier B . Glial Cell-Derived Neurotrophic Factor Induces Enteric Neurogenesis and Improves Colon Structure and Function in Mouse Models of Hirschsprung Disease. Gastroenterology. 2020; 159(5):1824-1838.e17. DOI: 10.1053/j.gastro.2020.07.018. View

4.
Nakatani T, Iwasaki M, Yamamichi A, Yoshioka Y, Uesaka T, Bitoh Y . Point mutagenesis in mouse reveals contrasting pathogenetic effects between MEN2B- and Hirschsprung disease-associated missense mutations of the RET gene. Dev Growth Differ. 2020; 62(4):214-222. DOI: 10.1111/dgd.12664. View

5.
Tan K, Mo J, Li M, Dong Y, Han Y, Sun X . SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma. J Exp Clin Cancer Res. 2022; 41(1):352. PMC: 9764568. DOI: 10.1186/s13046-022-02563-3. View